Targeting FDX1 by trilobatin to inhibit cuproptosis in doxorubicin‐induced cardiotoxicity. - Wei, Jiajia; Lan, Guozhen; Zhang, Wenfang; Ran, Wang; Wei, Yu; Liu, Xin; Zhang, Yuandong; Gong, Qihai; Li, Haibo; Gao, Jianmei (British Journal of Pharmacology, 2025)